[The future of the treatment of insulin-dependent diabetes mellitus].
Reach
G
G
Inserm U341, génie biomédical et diabète sucré, service de diabétologie, Hôtel-Dieu, Paris, France.
D000818:Animals; D001786:Blood Glucose / Q000032:analysis; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D004333:Drug Administration Routes; D005544:Forecasting; D006801:Humans; D007279:Injections, Subcutaneous; D007328:Insulin / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000627:therapeutic use*; D007332:Insulin Infusion Systems; D016381:Islets of Langerhans Transplantation; D016035:Pancreas Transplantation; D012106:Research; D014183:Transplantation, Heterologous
D001786:Blood Glucose; D007328:Insulin
L'avenir du traitement du diabète sucré insulinodépendant.